Target intelligence / Profile preview

Oxalobacter formigenes-derived factor receptor

Molecular classification
Receptor, G protein-coupled receptor (putative)
01

Overview

The Oxalobacter formigenes-derived factor receptor is a putative cell-surface receptor located on the apical membrane of intestinal epithelial cells that mediates the action of secretagogues produced by the gut commensal bacterium Oxalobacter formigenes (Arvans et al., 2017). These secretagogues, recently identified as Sel1-like proteins and specific derived peptides known as P8 and P9, trigger a signaling cascade involving Protein Kinase A (PKA) upon binding to the receptor (Arvans et al., 2023). Activation of this pathway leads to the upregulation and increased apical membrane expression of the oxalate transporters SLC26A6 and SLC26A2 (Hassan, Grantome). This process enhances enteric oxalate secretion, which effectively reduces the systemic absorption of oxalate and its subsequent excretion in the urine. Consequently, this receptor is a significant therapeutic target for the treatment of hyperoxaluria and the prevention of calcium oxalate kidney stones. While the exact molecular identity of the receptor remains to be fully characterized, evidence suggests it may belong to the G protein-coupled receptor (GPCR) family and potentially involve adenosine receptor signaling pathways (Musch et al., 2023).

Other names
Oxalobacter formigenes secretagogue receptorSel1-like protein receptorP8/P9 peptide receptorPutative intestinal oxalate secretagogue receptor
02

Mechanism of action

Agonism of the receptor triggers a PKA-dependent signaling pathway that increases the apical membrane recruitment and transport activity of SLC26A6 and SLC26A2, thereby stimulating intestinal oxalate secretion.

03

Biological functions

Signal transductionIon transport regulationOxalate homeostasisEnteric secretion
04

Disease associations

Nephrolithiasis (Kidney stones)Hyperoxaluria (Primary and Enteric)Chronic kidney diseaseHyperoxalemia
05

Safety considerations

Potential off-target effects of systemic PKA activationAlterations in intestinal electrolyte and water transportGastrointestinal motility changesLong-term effects of chronic enteric secretion stimulation
06

Interacting drugs

Sel1-like proteins

3 more in the full profile.

07

Biomarkers

Urinary oxalate concentrationPlasma oxalate concentrationSLC26A6 apical membrane expressionIntestinal oxalate secretion rate

Beyond the preview

Go deeper on Oxalobacter formigenes-derived factor receptor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxalobacter formigenes-derived factor receptor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call